CLDX

Celldex Therapeutics
CLDX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.41B
EV
$741.68M
Shares Outstanding
66.39M
Beta
1.14

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$58.54
P/E 2025E
-
P/Revenue 2025E
279.38x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Celldex Therapeutics, Inc.

gainify
CLDX

Celldex Therapeutics, Inc.

CLDX

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic...

Sector

Healthcare

Industry

Biotechnology

CEO

Marucci, Anthony

Employees

186

IPO Date

1986-05-15

Headquarters

Perryville III Building, Suite 220, 53 Frontage Road, Hampton, New Jersey, 08827, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.